Stay updated on CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.

Latest updates to the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s footer “Revision” version number was updated from v3.5.2 to v3.5.3, indicating a platform/document revision rather than a change to study information.SummaryDifference0.0%

- Check27 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2. No study data or user-facing functionality appears to be changed.SummaryDifference0.0%

- Check91 days agoChange DetectedAdded site revision v3.4.2 and removed the earlier v3.4.1 funding/operations notice; changes are limited to system messages and do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check99 days agoChange Detected- Added a site-wide notice regarding government funding lapse and NIH CC operating status. - Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.